MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-HP-11-0003729
Ciel Pharma Private Limited
Ciel Pharma Private Limited - pharma in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹2.2 Cr
▲ 20% YoY
Net loss · FY 2022
₹52,130
Net margin -0.2%
EBITDA · FY 2022
₹17.88 Lakh
EBITDA margin 8.1%
Authorised capital
₹2.5 Cr
Registered with MCA
Paid-up capital
₹2.17 Cr
Issued & subscribed
Open charges
₹4.6 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
About Ciel Pharma Private Limited
Data last updated:
Ciel Pharma Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 June 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2011PTC045378. Its GSTIN is 09AAECC4578N1Z0 (Uttar Pradesh). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.17 Cr. It is led by directors Muneesh Kumar Dogra and Garima Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 647A/007 Gudian Purwa Behind Arihant Hospital Jankipuram, Lucknow, Uttar Pradesh, India – 226021.
As per the financials filed for FY 2022, the company reported a revenue of ₹2.2 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net loss of ₹52,130 (net margin -0.2%) and EBITDA of ₹17.88 Lakh (EBITDA margin 8.1%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 12% over five years.
As per MCA filings, the company has open charges of ₹4.6 Cr on record. Court records list 3 cases involving the company, including 3 filed against it; 2 cases are pending.
Ciel Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0003729). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233UP2011PTC045378
Registration Number 045378
Incorporation Date 21 June 2011
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HP-11-0003729
Recognitions & Rankings of Ciel Pharma
Contact details
Ciel Pharma Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address647A/007 Gudian Purwa Behind Arihant Hospital Jankipuram, Lucknow, Uttar Pradesh, India – 226021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ciel Pharma Private Limited, buy the company report.
Comprehensive company report
Ciel Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ciel Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ciel Pharma Private Limited, buy the company report.
Financials of Ciel Pharma Private Limited
FY 2022 filings availableCiel Pharma Private Limited reported revenue of ₹2.2 Cr (up 20% YoY) for FY 2022.
Revenue · FY 2022
₹2.2 Cr ▲ 20%
Net loss · FY 2022
₹52,130 margin -0.2%
EBITDA · FY 2022
₹17.88 Lakh margin 8.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 20%
3 years · compounded
▼ 18%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 28%
3 years · compounded
▲ 36%
5 years · compounded
▲ 96%
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 20% growth in the latest year. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹2.2 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.88 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹52,130 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.1% | ||||
| Net Profit Margin | -0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ciel Pharma Private Limited, buy the company report.
Board of directors of Ciel Pharma Private Limited
Ciel Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Muneesh Kumar Dogra Also directs: Cielprints LLP | Director | 17 Jan 2020 | 6 Years 9 Months | Current |
| Garima Tiwari Also directs: Cielprints LLP | Director | 01 Jan 2020 | 6 Years 9 Months | Current |
Peer comparison
Ciel Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Esvy Life Sciences Private Limited | ₹2.21 Cr (FY 2025) | 20.0% | Begumpet, Hyderabad, Telangana, India | |||
| Ciel Pharma Private Limitedthis company | ₹2.2 Cr (FY 2022) | -₹52,130 | -0.2% | 20.0% | Lucknow, Uttar Pradesh, India | |
| Hariansh Pharmaceuticals Private Limited | ₹2.19 Cr (FY 2024) | 270.0% | Nashik, Maharashtra, India | |||
| Cellbless Healthcare Private Limited | ₹2.19 Cr (FY 2023) | 0.0% | Lucknow, Uttar Pradesh, India | |||
| Maccare Drugs Private Limited | ₹2.18 Cr (FY 2025) | 12.0% | Meerut, Uttar Pradesh, India |
To see the full peer comparison of Ciel Pharma Private Limited, buy the company report.
Auditor
Ciel Pharma Private Limited is audited by DEEPAK AGARWAL & CO. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DEEPAK AGARWAL & CO. | FY 2022 | 023998C |
Shareholding
The shareholding of Ciel Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ciel Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.6 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 May 2022 | 100578717 | Sidbi | ₹4.4 Cr | Open | |
| 11 Nov 2020 | 100411699 | Hdfc Bank Limited | ₹20.36 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
Ciel Pharma Private Limited has 3 court cases on record: 3 filed against it. 2 cases are pending and 1 is disposed.
Total cases
3
Filed against the company
3
Pending
2
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 2 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Amroha, Uttar Pradesh | Criminal case | Filed against the company | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed against the company by Doshi Pharmaceutical | Pending |
| District court, Mathura, Uttar Pradesh | Criminal case | Filed against the company by State Government | Disposed |
To see the full case history of Ciel Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ciel Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ciel Pharma has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECC4578N1Z0 | Uttar Pradesh | Active | 01 Jul 2017 |
| 02AAECC4578N1ZE | Himachal Pradesh | Active | 26 Jun 2018 |
To see the full GST registrations and return filing status of Ciel Pharma Private Limited, buy the company report.
Recent activity
Ciel Pharma Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Pankaj Kumar Dogra ceased to be Director on 26 Aug 2021.
AGM
Ciel Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Charges
A charge with Sidbi amounted to Rs. 4.40 Cr with Charge ID 100578717 was registered on 31 May 2022.
Filing
Ciel Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Kanpur.
Ceased
Pankaj Kumar Dogra ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 100411699 was registered on 11 Nov 2020.
Ceased
Meera Dogra ceased to be Director.
Appointed
Muneesh Kumar Dogra was appointed as Director.
Appointed
Garima Tiwari was appointed as Director.
Incorporation
21 Jun 2011
Ciel Pharma Private Limited was registered on 21 Jun 2011 with Roc Kanpur & aged 15 years 4 months as per MCA records.
Frequently asked questions
Ciel Pharma is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 June 2011 (15+ years old) and is registered under CIN U24233UP2011PTC045378.
Ciel Pharma has 2 current directors:
- Muneesh Kumar Dogra - Director
- Garima Tiwari - Director
The latest financial statements of Ciel Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
The GSTIN of Ciel Pharma is 09AAECC4578N1Z0, registered in Uttar Pradesh. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 02AAECC4578N1ZE (Himachal Pradesh).
The CIN (Corporate Identification Number) of Ciel Pharma is U24233UP2011PTC045378. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ciel Pharma has 3 court cases on record: 3 filed against it. 2 are pending.
Ciel Pharma was incorporated on 21 June 2011, making it 15+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Ciel Pharma by revenue are Esvy Life Sciences Private Limited, Hariansh Pharmaceuticals Private Limited, Cellbless Healthcare Private Limited, Maccare Drugs Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Pankaj Kumar Dogra ceased to be Director on 26 Aug 2021. Meera Dogra ceased to be Director on 02 May 2020. Muneesh Kumar Dogra was appointed as Director on 17 Jan 2020. Ciel Pharma has 4 board changes on record in total.
Yes, Ciel Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HP-11-0003729).
The registered office of Ciel Pharma is at 647A007 Gudian Purwa Behind Arihant Hospital Jankipuram, Lucknow, Uttar Pradesh, India – 226021.